Wilfred E Jaeger
CIK 1190474 · last filed 2023-05-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NVRO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3200 ALPINE RD
PORTOLA VALLEY, CA 94028
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STIM | Director | 138,563 | $2.23 | $309.0K | $113.3K | 11 | 2023-05-30 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Director | 0 | $8.37 | $0 | -$9.27M | 11 | 2023-03-06 |
| NEVRO CORP (NVRO) Delisted | Director | 12,698 | $5.84 | $74.2K | -$103.28M | 20 | 2020-05-26 |
| Molecular Templates, Inc. (THLD) Delisted | Director | 4,773 | — | — | -$17.52M | 27 | 2016-06-28 |
| TALPHERA, INC. (ACRX) Delisted | 10%+ Owner | — | $0.86 | — | $0 | 1 | 2011-02-18 |
| EPOCRATES INC (EPOC) Delisted | 1,655,329 | — | — | -$18.70M | 1 | 2011-02-07 | |
| Molecular Templates, Inc. (THLDD) Delisted | Director | 70,764 | — | — | $2.00M | 1 | 2008-09-03 |
| NORTH AMERICAN SCIENTIFIC INC (NASI) Delisted | Director | 17,913,296 | — | — | $0 | 2 | 2008-05-01 |
Recent Filings · Page 4 of 8
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-17 | NEVRO CORP (NVRO) Delisted | Sell (S) | −155,160 | -$15.10M | EDGAR |
| 2016-06-28 | Molecular Templates, Inc. (THLD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-20 | NEVRO CORP (NVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-19 | NEVRO CORP (NVRO) Delisted | Sell (S) | −112,983 | -$7.31M | EDGAR |
| 2016-03-01 | Molecular Templates, Inc. (THLD) Delisted | Other (J) | −27,500 | $0 | EDGAR |
| 2015-12-16 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Sell (S) | −206,562 | -$4.14M | EDGAR |
| 2015-11-24 | NEVRO CORP (NVRO) Delisted | Sell (S) | −25,000 | -$1.34M | EDGAR |
| 2015-11-19 | NEVRO CORP (NVRO) Delisted | Sell (S) | −175,000 | -$9.14M | EDGAR |
| 2015-08-14 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Sell (S) | −293,355 | -$5.13M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.